Longeveron Inc. (LGVN)
Nasdaq: LGVN · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 2017
Who owns Longeveron Inc.
As filed with the SECHolders of 5% or more
4
Mitchell P. Kopin holds 9% of Class A Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
20
report now, of 30 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Mitchell P. Kopin
SCHEDULE 13G/A · filed Aug 13, 2026 · Class A Common Stock, par value $0.001 per share · 9.99% in Aug 15, 2025
Logos Global Management LP
SCHEDULE 13G · filed Sep 10, 2026 · Class A Common Stock
Janus Henderson Group PLC
SCHEDULE 13G · filed May 15, 2026 · Class A Common Stock
Integrated Core Strategies (US) LLC
SCHEDULE 13G · filed Aug 10, 2026 · Class A Common Stock, par value $0.001 per share
Lincoln Alternative Strategies LLC
SCHEDULE 13G/A · filed Feb 10, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 6.09% in Aug 27, 2025
What LGVN reports owning in othersstakes of 5% or more, and other ties
Longeveron Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 5, 2025 to Oct 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Oct 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.